Navigation Links
BioDrain Medical Inc. Signs Additional Independent Distribution Agreements, Strengthening Nationwide Presence
Date:7/20/2012

MINNEAPOLIS, July 20, 2012 /PRNewswire/ -- BioDrain Medical Inc. (OTCBB: BIOR, OTCQB: BIOR) ("BioDrain"), producer of the FDA-cleared automated surgical fluid disposal device, the STREAMWAY® System, announced today that it has signed several new agreements with independent distributors and is in discussions regarding potential contracts with other independent distributors.

The addition of these recently signed agreements with independent distribution partners is intended to broaden BioDrain's geographical distribution coverage from a few states to approximately 50% of the U.S., according to Joshua Kornberg, President and CEO of BioDrain. He noted that while BioDrain continues to work towards signing agreements with other independent distributor groups, potential national sales partners have expressed strong interest in BioDrain's STREAMWAY System as well.

"Several potential national sales partners, each with between 1000-2000 sales representatives, have expressed strong interest in our product and we are pleased that that our negotiations with these potential sales partners are underway," said Mr. Kornberg. "The representatives of the distributor groups with which we have signed agreements have met BioDrain's criteria for distribution partnership, including a history of successfully selling multiple product lines in either Orthopedics or Surgery, a satisfactory representative-to-customer ratio, and, we believe, a readiness to successfully launch the STREAMWAY System as BioDrain's partners."

Mr. Kornberg continued, "While we strive to establish partnerships with national sales forces and more independent distributors, our in-house sales department continues to uncover leads and seeks to drive sales independently of our distributor covered states, and we are also dedicating additional resources towards national sales conventions and journal advertising. We believe we have a superior technology compared to leading canister-based competitors, and with increases in our resourcing capabilities and our sales representation, we believe that we will be in a much better position to capture a sizeable share of the market in the near future."   

About BioDrain Medical, Inc. 
BioDrain Medical, Inc. has a fully automated, patented, FDA-cleared, surgical fluid disposal system that virtually eliminates operating room workers' exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment. Today's manual surgical fluid handling methods of hand-carrying filled surgical fluid canisters and emptying these canisters is an exposure risk and an antiquated approach to the handling of surgical fluid waste. BioDrain's STREAMWAY System fully automates the collection, measurement and disposal of surgical fluids resulting in: 1) reducing overhead costs to hospitals and surgical centers, 2) improving the Occupational State and Health Association (OSHA) and other regulatory compliance, and 3) improving the efficiency of the operating room (and thereby making surgeries more profitable).

BioDrain's STREAMWAY System is eco-friendly as it contributes to cleaning up the environment. Currently, approximately 50 million bloody, potentially disease infected canisters go to landfills annually in the United States. These tainted canisters can remain in landfills for years to come. With the installation of BioDrain's STREAMWAY System, the number of canisters can be significantly reduced. BioDrain Medical Inc. makes the operating room and our environment safer, cleaner, and better. BioDrain products are currently being represented by independent professional sales representatives that cater to the needs of hospitals and ambulatory surgical centers across the country. For additional information, please visit: www.biodrainmedical.com.

Forward-looking Statements:
Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the company's ability to implement its long range business plan for various applications of its technology; the company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the company's reports filed with the Securities and Exchange Commission. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the company's financial position. See the company's most recent Quarterly Report on Form 10-Q and  8-K filings since then.

Investor Contact:

Mr. Kevin Fickle, President 
NUWA Group LLC 
Tel: +1-925-330-8315            
Email: kevin@nuwagroup.com

 

 


'/>"/>
SOURCE BioDrain Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioDrain Medical, Inc. Implements Initiatives to Position Itself for Sustained Growth
2. Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27, 2012
3. Ellman International Launches Multi-stage Growth Plan With Acquisition Of Sandstone Medical Technologies
4. Mindray Medical Completes Acquisition of Dragonbios Orthopedics Business
5. Concord Medicals Changan Hospital and Fox Chase Cancer Center Sign Strategic Alliance Agreement
6. Nonin Medical Named Platinum Partner by Tri-anim Health Services
7. Equinoxo2 Medical Announces Distribution of a New Portable Device
8. University of Ottawa Medical Research Arm Eliminates Storage Boundaries with EMC Isilon
9. The Biomedical Device Industry in America: Challenges at Home and Abroad
10. European Commission Grants Orphan Medicinal Product Designation for Emmaus Medicals Sickle Cell Treatment
11. Merit Medical Systems Announces Earnings Release Date/Time And Conference Call Information For The Second Quarter Ended June 30, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... 24, 2017 Solentim, the developer of ... addition of a major new product line called ... The VIPS has been developed for automatically seeding ... as part of the process to generate clonally-derived ... and more reliable solution when compared to traditional ...
(Date:4/20/2017)... April 20, 2017  Zimmer Biomet Holdings, Inc. (NYSE ... today announced that it will be participating in the ... the InterContinental Hotel in Boston, Massachusetts ... present at 11:20 a.m. Eastern Time. A ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com .  ...
(Date:4/20/2017)... April 20, 2017  CVS Pharmacy, the retail ... a new store design to enhance the retail ... food, health-focused products and expanded beauty selections paired ... customers discover new offerings. Together with its innovative ... of the customer experience at CVS Pharmacy.  ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, developer, ... strategic partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable ... management of complex spine deformity cases, particularly in children. , GSO’s focus is ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement earlier ... position. The former overall number one pick in the 2001 NFL Draft, to the ... the record for the most career rushing yards by a quarterback (6,109) and the ...
(Date:4/24/2017)... ... ... As part of the nationwide Days of Remembrance effort led by the ... Nazi persecution, Center for Medicine after the Holocaust (CMATH) announced that it ... Germany and Poland next week. , The Fourth Biennial CMATH Champions Trip to Germany ...
(Date:4/24/2017)... ... 24, 2017 , ... Today, Bright Pink , a national non-profit organization focusing on the ... CEO. , Bright Pink is proud to announce Katie Thiede as their new Chief ... new role as Chairman of the Board and launched a national search to find ...
(Date:4/24/2017)... ... April 24, 2017 , ... Veteran Theresa James awoke to the ... life forever. , In “Healing Tears,” James depicts every parent’s worst nightmare, when her ... I began journaling conversations and situations throughout my divorce,” James said. “After the death ...
Breaking Medicine News(10 mins):